[HTML][HTML] Gs/Gq signaling switch in β cells defines incretin effectiveness in diabetes

OS Oduori, N Murao, K Shimomura… - The Journal of …, 2020 - Am Soc Clin Investig
OS Oduori, N Murao, K Shimomura, H Takahashi, Q Zhang, H Dou, S Sakai, K Minami…
The Journal of clinical investigation, 2020Am Soc Clin Investig
Patients with type 2 diabetes (T2D) fail to secrete insulin in response to increased glucose
levels that occur with eating. Glucagon-like peptide-1 (GLP-1) and glucose-dependent
insulinotropic polypeptide (GIP) are two incretins secreted from gastrointestinal cells that
amplify insulin secretion when glucose is high. In this issue of the JCI, Oduori et al. explore
the role of ATP-sensitive K+(KATP) channels in maintaining glucose homeostasis. In
persistently depolarized β cells from KATP channel knockout (KO) mice, the researchers …
Abstract
Patients with type 2 diabetes (T2D) fail to secrete insulin in response to increased glucose levels that occur with eating. Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are two incretins secreted from gastrointestinal cells that amplify insulin secretion when glucose is high. In this issue of the JCI, Oduori et al. explore the role of ATP-sensitive K+(KATP) channels in maintaining glucose homeostasis. In persistently depolarized β cells from KATP channel knockout (KO) mice, the researchers revealed a shift in G protein signaling from the Gs family to the Gq family. This shift explains why GLP-1, which signals via Gq, but not GIP, which signals preferentially via Gs, can effectively potentiate secretion in islets from the KATP channel–deficient mice and in other models of KATP deficiency, including diabetic KK-Ay mice. Their results provide one explanation for differential insulinotropic potential of incretins in human T2D and point to a potentially unifying model for T2D progression itself.
The Journal of Clinical Investigation